Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980...

Area of Science:

• Neuroscience
• Epidemiology
• Pharmacology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder with significant public health implications.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) have been investigated for their potential neuroprotective effects.

Purpose of the Study:

• To investigate the association between nonsteroidal anti-inflammatory drug (NSAID) use and the risk of developing Alzheimer's disease (AD).

Main Methods:

• A retrospective case-control study was conducted using data from the Rochester Epidemiology Project.
• 302 incident cases of Alzheimer's disease (AD) were compared with age- and sex-matched controls.
• Exposure to prescription NSAIDs was defined as use for 7 or more days within a specific 2-year period.

Main Results:

• The overall odds ratio (OR) for NSAID exposure versus no NSAID exposure was 0.79 (95% CI, 0.45 to 1.38).
• The OR for men was 0.40 (95% CI, 0.13 to 1.29), and for women, it was 1.00 (95% CI, 0.52 to 1.92).
• Aspirin exposure showed an OR of 0.90 (95% CI, 0.54 to 1.50) compared to no NSAID exposure.

Conclusions:

• The study suggests a possible protective effect of NSAIDs against Alzheimer's disease (AD).
• However, these findings are not conclusive and require further investigation to confirm the association.